UAB 0775 Phase II Trial of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Protocol From HLA Matched Related Donors for The Treatment of Patients With Low Grade B Cell Malignancies.

Trial Profile

UAB 0775 Phase II Trial of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Protocol From HLA Matched Related Donors for The Treatment of Patients With Low Grade B Cell Malignancies.

Discontinued
Phase of Trial: Phase II/III

Latest Information Update: 26 Jul 2017

At a glance

  • Drugs Fludarabine (Primary)
  • Indications B cell lymphoma; Graft-versus-host disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Feb 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 10 Sep 2012 Planned end date changed from 1 Jan 2014 to 1 Jan 2015 as reported by ClinicalTrials.gov.
    • 04 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top